NorthWest Biotherapeutics Inc (NWBO)

[User-840664]

Well I'm glad you can at least acknowledge something..

As for approval, no one knows what will happen but the IP is dated, the trial was flawed and the UCLA trials ( owned by UCLA) use a different and more effective formula.

You must also know that even if approved, NWBO gets a small royalty from any sales, after Advent's costs- Advent books ALL revenues. It is very expensive and the UK market is very small, relatively speaking. My assessment is that NWBO is already way over valued based on the best case #s.

See below
https://www.investorvillage.com/uploads/88540/files/Advent.pdf